Anti-proliferative therapy for HIV cure: a compound interest approach

In the era of antiretroviral therapy (ART), HIV-1 infection is no longer tantamount to early death. Yet the benefits of treatment are available only to those who can access, afford, and tolerate taking daily pills. True cure is challenged by HIV latency, the ability of chromosomally integrated virus...

Descripción completa

Detalles Bibliográficos
Autores principales: Reeves, Daniel B., Duke, Elizabeth R., Hughes, Sean M., Prlic, Martin, Hladik, Florian, Schiffer, Joshua T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479830/
https://www.ncbi.nlm.nih.gov/pubmed/28638104
http://dx.doi.org/10.1038/s41598-017-04160-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479830/
https://www.ncbi.nlm.nih.gov/pubmed/28638104
http://dx.doi.org/10.1038/s41598-017-04160-3

Ejemplares similares